A Study on the Efficacy and Safety of Switching Between Two Targeted Strategies, HP+Chemotherapy and HPy+Chemotherapy, After Treatment Progression in HER-2 Positive Advanced or Metastatic Breast Cancer
Clinical trial NCT07455188 · RECRUITING
Trial details
- NCT number
- NCT07455188
- Sponsor
- Zhejiang Cancer Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-03-01
- Primary completion
- 2030-12-31
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.